G&S Capital LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 9,709 shares of the healthcare conglomerate’s stock, valued at approximately $3,353,000. UnitedHealth Group accounts for 1.2% of G&S Capital LLC’s investment portfolio, making the stock its 21st biggest position.
Other institutional investors also recently bought and sold shares of the company. StoneCrest Wealth Management Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at $222,000. Next Level Private LLC lifted its stake in shares of UnitedHealth Group by 21.4% during the third quarter. Next Level Private LLC now owns 1,239 shares of the healthcare conglomerate’s stock worth $445,000 after purchasing an additional 218 shares in the last quarter. Invested Advisors acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $266,000. Investors Asset Management of Georgia Inc. GA ADV lifted its position in UnitedHealth Group by 7.0% during the 3rd quarter. Investors Asset Management of Georgia Inc. GA ADV now owns 769 shares of the healthcare conglomerate’s stock worth $266,000 after acquiring an additional 50 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC grew its position in UnitedHealth Group by 28.0% in the third quarter. Kingswood Wealth Advisors LLC now owns 8,862 shares of the healthcare conglomerate’s stock valued at $3,060,000 after acquiring an additional 1,941 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
UNH has been the subject of several analyst reports. Mizuho upped their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Royal Bank Of Canada lifted their target price on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Sanford C. Bernstein raised their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. UBS Group upped their target price on UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Finally, Evercore ISI upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.75.
UnitedHealth Group Trading Up 1.4%
UnitedHealth Group stock opened at $346.57 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The firm’s 50-day moving average is $329.46 and its 200-day moving average is $320.79. The company has a market cap of $313.94 billion, a P/E ratio of 18.09, a PEG ratio of 2.06 and a beta of 0.42.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company posted $7.15 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
- Five stocks we like better than UnitedHealth Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
